oalib

OALib Journal期刊

ISSN: 2333-9721

费用：99美元

投稿

时间不限

( 2026 )

( 2025 )

( 2024 )

( 2023 )

自定义范围…

匹配条件： “Economic burden of disease” ，找到相关结果约1000条。
列表显示的所有文章，均可免费获取
第1页/共1000条
每页显示 条
Assessment of Knowledge and Attitude in a Sample of Patients with Rheumatoid Arthritis and Its Association with Disease Activity and Severity: A Cross-Sectional Study  [PDF]
Sami Salman, Ahmad SAlnuaimi, Nizar Abdul Lateef, Rana Kadhum
Open Journal of Rheumatology and Autoimmune Diseases (OJRA) , 2014, DOI: 10.4236/ojra.2014.44031
Abstract: Background: Rheumatoid arthritis (RA) is a chronic and disabling disease that has a major impact on the lives of patients. Objectives: To test the patients’ knowledge about their disease, its treatment, its complications, and if this affects severity of the disease as measured by the disease activity index (DAS 28). Patients and Methods: A sample of 100 patients with RA who met the Criteria of American College of Rheumatology for RA agreed to participate in this study over the period September 2011-March 2012. Patients’ data were obtained by personal interview. The questionnaire included demographic characteristics and the patients’ knowledge about their disease. The disease activity was measured using standard (DAS28). Results: Thirty three percent of the patients didn’t have an idea about their disease, 20% didn’t know the reason for the investigations, 49% didn’t know the treatment and 40% didn’t know the side effects of their medications. Most patients had a high disease activity index, and there was a poor correlation between patients’ educational level and the disease activity. Conclusions: Neither the educational level nor the frequency of hospital admissions had effects on the knowledge about this disease. As most patients had a high disease activity, a better knowledge may improve disease control and prevent complications.
Los QALYs y DALYs como indicadores sintéticos de salud
ALVIS,NELSON; VALENZUELA,MARíA TERESA;
Revista médica de Chile , 2010, DOI: 10.4067/S0034-98872010001000005
Abstract: this article is a revision of the genesis and use of the health synthetic indicators qalys and dalys. the chronology of their appearance is shown and similarities and differences between them stated. dalys (disability-adjusted life-years) correspond to years of life that are adjusted by a certain level of disability experienced during a particular period of time. dalys, by studying disease burden, summarize the impact of mortality and disability related to specific disease in different communities. on the other hand, qalys (quality-adjusted life-years) summarize health results in an indicator that combines the number of years lived with the quality of life experienced over those years. qalys and dalys play a crucial role as results measures in economic evaluation studies (cost-effectiveness and cost-utility analysis) measuring the impact of actions or specific interventions in the reversion of disease burden (dalys) and/ or the improvement of the quality of life and life expectancy of patients (qalys). their generic character allows the comparison of the impact of health interventions for different diseases.
Impact of Cardiovascular Disease on Health Insurance Coverage and Healthcare Use under Economic Stress: The National Health and Nutrition Examination Survey, 2003–2012
Dong Chen,Hong Lai,Ji Li,Shaoguang Chen,Shenghan Lai
- , 2019, DOI: 10.24171/j.phrp.2019.10.3.03
Abstract: Cardiovascular disease (CVD) has a substantial financial impact on healthcare systems in the US. This study aimed to examine the impact of CVD on health insurance coverage and health service use under economic stress as indicated by the Great Recession in the US (December 2007–June 2009)
Economic burden of chronic bronchitis in the United States: a retrospective case-control study
Christopher M Blanchette, Melissa H Roberts, Hans Petersen, et al
International Journal of Chronic Obstructive Pulmonary Disease , 2011, DOI: http://dx.doi.org/10.2147/COPD.S15882
Abstract: onomic burden of chronic bronchitis in the United States: a retrospective case-control study Original Research (3984) Total Article Views Authors: Christopher M Blanchette, Melissa H Roberts, Hans Petersen, et al Published Date January 2011 Volume 2011:6 Pages 73 - 81 DOI: http://dx.doi.org/10.2147/COPD.S15882 Christopher M Blanchette1, Melissa H Roberts1, Hans Petersen1, Anand A Dalal2, Douglas W Mapel3 1Division of Clinical and Outcomes Research, Lovelace Respiratory Research Institute, Kannapolis, NC, USA; 2US Health Outcomes, GlaxoSmithKline, Research Triangle Park, NC, USA; 3Lovelace Clinic Foundation, Albuquerque, NM, USA Background: Chronic bronchitis (CB) is often misdiagnosed or diagnosed at a later stage of chronic obstructive pulmonary disease (COPD). We examined how this later diagnosis may impact health care costs and utilization during the 12 months prior to and 24 months post initial CB diagnosis. Methods: This retrospective case-control analysis used claims data from a large US database from July 1, 2003 through June 30, 2007. Patients with CB aged 40 years and older were propensity matched (N = 11,674) to patients without evidence of COPD or asthma by demographics, CB diagnosis quarter/year, and comorbidities. Group differences were assessed using Student's t-test and Pearson chi-square test statistics. Results: Six months prediagnosis, CB patients had higher frequencies of any hospitalization (9.6%, 6.7%; P < 0.05), emergency department/urgent care visits (13.3%, 6.7%; P < 0.05), and prescriptions (97.3%, 94.1%; P < 0.05). Six months postdiagnosis, CB patients had 5.6 times more hospitalizations (P < 0.05) and 3.1 times more emergency department/urgent care visits (P < 0.05) compared with controls. Mean total costs (US$) for CB patients 12 months prediagnosis were significantly higher than controls (months 12–7: $4212, $3826; P < 0.05; months 6–1: $5289, $4285; P < 0.05). CB patients had higher mean total costs ($8919; P < 0.05) 6 months postdiagnosis. Costs remained $2429 higher for CB patients 19–24 months postdiagnosis (P < 0.05). Conclusion: Health care costs and utilization among CB patients are increased both prior to diagnosis and during the 2 years postdiagnosis. This study suggests that not accurately diagnosing CB early has a substantial impact on health care costs, and that the economic burden for CB patients remains elevated even after adjustment for comorbidities associated with COPD.
When Does an Immigrant with HIV Represent an Excessive Demand on Canadian Health or Social Services?
PETER COYTE,KEDNAPA THAVORN
Aporia : The Nursing Journal , 2010,
Abstract: The Canadian Immigration and Refugee Protection Act of 2001 outlines conditions under which individuals may be granted or denied admission to Canada. The Act stipulates that applications for residence will be rejected if their health is expected to generate excessive demand on Canadian health or social services. The purpose of this paper is to derive a statistical definition of excessive demand and to apply that threshold to persons with HIV who are seeking admission to Canada. The paper demonstrates that the current threshold used by Citizenship and Immigration Canada is much lower than the thresholds that may be derived statistically.
体力活动经济学价值的研究进展——基于第65届美国运动医学年会报告述评
Research Progress on the Economic Value of Physical Activity: Based on the Report of ACSM's 65th Annual Meeting
于洪军,成佳俐
- , 2018, DOI: 10.19582/j.cnki.11-3785/g8.2018.08.009
Abstract: 摘要：以介绍第65届美国运动医学大会暨第9届运动是良医世界大会的研究前沿和热点为目的。通过Morris/Paffenbarger 大会报告中体力活动的经济学价值为研究视角，对2007—2017年近10年该领域的研究趋势和格局进行了分析，并从体力活动经济性的理论机制、相关研究动态和对我国的启示展开分析，最后对该领域未来的发展趋势进行了展望。
Abstract: The purpose of this study was to review the frontier and hot topics of the ACSM’s 65th Annual Meeting and the 9th World Conference on Exercise Is Medicine (EIM) in 2018. From the perspective of the economic value of physical activity in the Morris/Paffenbarger report, this study analyzed the research trend and pattern in this field from 2007 to 2017, and analyzed the theoretical mechanism of the economic nature of physical activity, the relevant research trends and the enlightenment to China. Finally, the future development of this field is discussed
Economic Burden Attributed to Children Presenting to Hospitals With Hand, Foot, and Mouth Disease in Vietnam
Angela Devine,Guy Thwaites,H Rogier van Doorn,Ho Lu Viet,Hoang Minh Tu Van,Hugo C Turner,Lam Anh Nguyet,Le Bich Lien,Le Nguyen Thanh Nhan,Le Nguyen Truc Nhu,Le Van Tan,Louise Thwaites,Nguyen Thanh Hung,Nguyen Thi Han Ny,Nguyen Thi Thu Hong,Nguyen Van Vinh Chau,Tran Tan Thanh,Tran Thi Lan Phuong,Trinh Huu Tung,Truong Huu Khanh
- , 2019, DOI: 10.1093/ofid/ofz284
Abstract: Hand, foot, and mouth disease (HFMD) has become a major public health concern in the Asia-Pacific region. Knowledge of its economic burden is essential for policy makers in prioritizing the development and implementation of interventions
A cost of illness study evaluating the burden of Wolfram syndrome in the United Kingdom
Annabel Griffiths,Richard Thompson,Sachin De Stone,Sana Eljamel,Timothy Barrett,Wrik Ghosh
- , 2019, DOI: 10.1186/s13023-019-1149-7
Abstract: Costs associated with different symptom groups. D deafness, DI diabetes insipidus, DIDMOAD diabetes insipidus, diabetes mellitus, optic atrophy and deafness (alternative name for Wolfram syndrome), DM diabetes mellitus, OA optic atroph
Burden of COPD in a government health care system: a retrospective observational study using data from the US Veterans Affairs population
Amir Sharafkhaneh, Nancy J Petersen, Hong-Jen Yu, et al
International Journal of Chronic Obstructive Pulmonary Disease , 2010, DOI: http://dx.doi.org/10.2147/COPD.S8047
Abstract: urden of COPD in a government health care system: a retrospective observational study using data from the US Veterans Affairs population Original Research (4854) Total Article Views Authors: Amir Sharafkhaneh, Nancy J Petersen, Hong-Jen Yu, et al Published Date April 2010 Volume 2010:5 Pages 125 - 132 DOI: http://dx.doi.org/10.2147/COPD.S8047 Amir Sharafkhaneh1,2, Nancy J Petersen2, Hong-Jen Yu2, Anand A Dalal3, Michael L Johnson2,4, Nicola A Hanania1 1Section of Pulmonary and Critical Care Medicine, Baylor College of Medicine, Houston, TX, USA; 2Houston VA HSR&D Center of Excellence, Department of Veterans Affairs Medical Center, Houston, TX, USA; 3GlaxoSmithKline, Research Triangle Park, NC, USA; 4University of Houston, College of Pharmacy, Houston, TX,USA Background: Health care utilization and costs among US veterans with chronic obstructive pulmonary disease (COPD) were compared with those in veterans without COPD. Methods: A cohort of veterans with COPD was matched for age, sex, race, and index fiscal year to a cohort of veterans without COPD (controls) using data from the Veterans Integrated Service Network (VISN) 16 from 10/1/1997 to 9/30/2004. Annual total and respiratory-related health care service utilization, costs of care, comorbidities, and respiratory medication use at the time of diagnosis were assessed. Results: A total of 59,906 patients with COPD were identified for a 7-year period prevalence of 8.2%, or 82 per 1000 population. Patients with COPD compared with controls had significantly higher all-cause and respiratory-related inpatient and outpatient health care utilization for every parameter examined including mean numbers of physician encounters, other outpatient encounters, emergency room visits, acute inpatient discharges, total bed days of care, and percentage of patients with any emergency room visits or any acute inpatient discharge. Patients with COPD had statistically significantly higher mean outpatient, inpatient, pharmacy, and total costs than the control group. The mean Charlson comorbidity index in patients with COPD was 1 point higher than in controls (2.85 versus 1.84, P < 0.001). 60% of COPD patients were prescribed medications recommended in treatment guidelines at diagnosis. Conclusion: Veterans with COPD compared with those without COPD suffer a tremendous disease burden manifested by higher rates of all-cause and respiratory-related health care utilization and costs and a high prevalence of comorbidities. Furthermore, COPD patients do not receive appropriate treatment for their disease on diagnosis.
Routine Preoperative Laboratory Testing: Economic Burden on Pre-Surgical Patients  [PDF]
Bright Ighodaro Obasuyi, Akwasi Antwi-Kusi
Open Journal of Anesthesiology (OJAnes) , 2017, DOI: 10.4236/ojanes.2017.71002
Abstract: Background: Routine pre-operative test, results in significant cost to the hospital and expense for the patient. The cost of a single laboratory test may be negligible but too many tests have increased cost for many national health schemes. Most of these patients cannot afford this extra cost thereby delaying surgery and adding up to emergencies. Implementation of change is necessary to reduce economic burden on the patient and enhance patient care. The aim of this study was to determine the economic burden of preoperative laboratory tests on pre-surgical patients in Komfo Anokye Teaching Hospital with a view to making appropriate recommendations that will reduce costs for the patients. Methodology: This was a prospective, cross-sectional study of patients undergoing elective surgery at K.A.T.H from 1st to 31st March 2014. A quantitative technique was used to effectively quantify laboratory results that were contained in a patient’s folder before an elective surgical procedure. Close and open ended questionnaire was developed and answered by reviewing patient’s folders during the pre-anaesthesia assessment. Cost of various laboratory investigations was obtained on request from one private laboratory and the KATH main laboratory. Data were analyzed using Statistical Package of Social Sciences (SSPS) version 22 and Microsoft Excel 2010. Results: The total cost of preoperative laboratory investigations in the study population was GHC 15, 321.19 (GHC 92.85 per individual); and for tests that were not indicated, GHC 3, 266.83 (GHC19.80 per individual). Conclusion: Routine preoperative laboratory tests ordered by Surgeons in Komfo Anokye Teaching Hospital impose an economic burden on the patients. The development of a comprehensive guideline that will help in the ordering of preoperative laboratory investigation will reduce costs for the
第1页/共1000条
每页显示 条


Home
Copyright © 2008-2020 Open Access Library. All rights reserved.